{
  "docId": "019de516-a80e-7369-bef2-cb942c391804",
  "docSlug": "7dbeec795af717930d34b2c0014ea723",
  "documentTitle": "Oculis | Results Presentation Deck | 33 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 33,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 40,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-a80e-7369-bef2-cb942c391804/19",
  "deckHref": "/decks/019de516-a80e-7369-bef2-cb942c391804",
  "deckJsonHref": "/decks/019de516-a80e-7369-bef2-cb942c391804.json",
  "deckAnchorHref": "/decks/019de516-a80e-7369-bef2-cb942c391804#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.039,
        "w": 0.118,
        "x": 0.85,
        "y": 0.05
      },
      "kind": "image",
      "text": "Oculis",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c01c71c-5de6-44bd-8729-158163118545",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.576,
        "x": 0.026,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "COVID-19: coronavirus disease 2019; TEAE: treatment-emergent adverse event; TE-SAE: treatment-emergent serious adverse event. Data, analysis, and conclusions are preliminary, and subject to change as full analysis is ongoing.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cac584c4-a62b-43ad-a4ef-585c07b1963f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.63,
        "w": 0.789,
        "x": 0.104,
        "y": 0.204
      },
      "kind": "table",
      "text": "OCS-01 (n = 119) Vehicle (n = 122) Events Patients, n (%) Events Patients, n (%) Any TEAE 60 35 (29.4) 102 45 (36.9) Any non-ocular TEAE 14 12 (10.1) 7 6 (4.9) Any ocular TEAE in the study eye 37 24 (20.2) 84 41 (33.6) Maximum severity of ocular TEAEs in the study eye Mild 14 (11.8) 21 (17.2) Moderate 9 (7.6) 19 (15.6) Severe 1 (0.8) 1 (0.8) Suspected treatment-related ocular TEAEs in the study eye 8 5 (4.2) 14 9 (7.4) Ocular TEAEs in the study eye leading to study drug discontinuation 3 (2.5) 10 (8.2) Any TE-SAE 0 0 1 1 (0.8) COVID-19 0 0 1 1 (0.8)",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61770631-2fbd-4eb5-996f-448dbf310b39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.73,
        "x": 0.026,
        "y": 0.055
      },
      "kind": "title",
      "text": "Overall Summary of Treatment-Emergent Adverse Events",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6742337-2d28-496f-84a1-195086105c6b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.019,
        "w": 0.156,
        "x": 0.026,
        "y": 0.09
      },
      "kind": "title",
      "text": "Safety population",
      "attrs": {},
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3cbc1982-f05d-429a-921f-16315cac8f23",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 8,
      "beatId": "7992b42b-1916-498c-b92e-c9642604a8e5",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document presents OCS-01 as a solution, highlighting its efficacy, safety, and potential value to stakeholders (slides 8-24).",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 8,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "8c374baa-88d9-4915-a041-aab0dfbd527a",
      "evidence": "The document presents OCS-01 as a solution that addresses the needs of patients and healthcare providers.",
      "position": 1,
      "objective": "How can OCS-01 address the needs of patients and healthcare providers in ocular surgery?",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}